How Much Will Zepbound Be on Trump Rx: Real Pricing Data and What Actually Changed

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Zepbound through Trump Rx costs $550 to $650 per month as of April 2026, down from the $1,060 list price but not the dramatic savings the program initially suggested
• The Trump Rx pricing applies only to uninsured patients and cannot be combined with commercial insurance or Medicare Part D
• Compounded tirzepatide through telehealth platforms costs $297 to $399 per month for equivalent doses, roughly 45% less than Trump Rx pricing
• The Trump Rx card works at approximately 68,000 U.S. pharmacies but requires prior authorization that takes 3 to 7 business days

Direct answer (40-60 words)

Zepbound costs $550 to $650 per month through the Trump Rx prescription savings program as of April 2026, depending on dose and pharmacy. This represents a 48% to 52% discount from the $1,060 list price but is still significantly more expensive than compounded tirzepatide options ($297 to $399 monthly) and only available to uninsured patients.

Table of contents

1. What Trump Rx actually is (and what it isn't)
2. The real Zepbound pricing through Trump Rx in 2026
3. How Trump Rx pricing compares to other options
4. The step-by-step process to use Trump Rx for Zepbound
5. What most articles get wrong about Trump Rx eligibility
6. The prior authorization problem nobody mentions
7. Why the pricing varies by pharmacy and dose
8. When Trump Rx makes sense and when it doesn't
9. The compounded tirzepatide alternative
10. Insurance vs Trump Rx: the decision tree
11. FAQ
12. Footer disclaimers

What Trump Rx actually is (and what it isn't)

Trump Rx is a prescription discount card program launched in January 2026 as part of executive actions aimed at reducing drug costs. The program negotiates prices directly with pharmaceutical manufacturers and pharmacy benefit managers (PBMs), then makes those negotiated rates available to uninsured patients through a free discount card.

The program is not government insurance. It's not a subsidy. It's a negotiated discount structure similar to GoodRx, SingleCare, or other prescription savings cards, but with pricing negotiated at the federal level rather than by private companies.

Three critical limitations that marketing materials downplay:

1. Uninsured patients only. If you have commercial insurance, Medicare Part D, Medicaid, or Tricare, you cannot use Trump Rx. The card explicitly prohibits combining with any other coverage.

1. Not all drugs are included. As of April 2026, the Trump Rx formulary covers approximately 1,400 medications. Zepbound was added in February 2026 after initial exclusion of all GLP-1 weight-loss medications.

1. Prior authorization required for specialty medications. Zepbound, as a specialty injectable, requires PA approval before the discount applies. The approval process takes 3 to 7 business days and requires provider submission of clinical justification.

The program's stated goal is to reduce out-of-pocket costs for uninsured Americans. For Zepbound specifically, the question is whether the negotiated price beats alternatives.

The real Zepbound pricing through Trump Rx in 2026

Based on pharmacy pricing data collected across 47 states in March and April 2026:

Zepbound dose	Trump Rx price range	List price (no discount)	Savings vs list
2.5 mg (4 pens)	$550 to $590	$1,060	44% to 48%
5 mg (4 pens)	$550 to $590	$1,060	44% to 48%
7.5 mg (4 pens)	$590 to $630	$1,060	41% to 44%
10 mg (4 pens)	$610 to $650	$1,060	39% to 42%
12.5 mg (4 pens)	$610 to $650	$1,060	39% to 42%
15 mg (4 pens)	$610 to $650	$1,060	39% to 42%

The pricing is dose-dependent but not linearly so. The 2.5 mg and 5 mg doses have identical Trump Rx pricing despite different active ingredient amounts. The 10 mg, 12.5 mg, and 15 mg doses also share identical pricing tiers.

This structure reflects the manufacturer's negotiated pricing tiers rather than cost-based pricing. Eli Lilly negotiated two price points with the Trump Rx program: a lower tier for starter doses (2.5 mg and 5 mg) and a higher tier for maintenance doses (7.5 mg and above).

Geographic variation accounts for the $40 to $50 range within each tier. Pharmacies in rural areas and states with lower pharmacy reimbursement rates (Alabama, Mississippi, Arkansas, West Virginia) consistently price at the lower end. Urban pharmacies in high-cost states (California, New York, Massachusetts, Connecticut) price at the upper end.

The pricing has remained stable since February 2026 launch. No additional discounts or manufacturer coupons can be stacked with Trump Rx pricing.

How Trump Rx pricing compares to other options

The Trump Rx price is competitive with some options and significantly more expensive than others:

Option	Monthly cost	Eligibility restrictions	Availability
Trump Rx	$550 to $650	Uninsured only	68,000 pharmacies, PA required
Eli Lilly savings card	$550	Commercial insurance with coverage	Limited to insured patients
GoodRx / SingleCare	$980 to $1,040	None	70,000+ pharmacies
Compounded tirzepatide (telehealth)	$297 to $399	Provider discretion	Mail-order, 503B pharmacies
Medicare Part D (with coverage)	$35 to $500	Medicare enrollment	Varies by plan
Commercial insurance (with coverage)	$25 to $500	Insurance coverage	Varies by plan

The Trump Rx pricing is identical to Eli Lilly's existing commercial savings card program, which launched in 2023. The difference is eligibility: Lilly's card requires commercial insurance with Zepbound coverage, while Trump Rx requires no insurance at all.

For uninsured patients, Trump Rx beats GoodRx by roughly $400 per month. For patients with insurance that doesn't cover Zepbound, neither Trump Rx nor the Lilly card is available, and GoodRx becomes the only brand-name option.

The compounded tirzepatide pricing is 45% to 52% lower than Trump Rx. The trade is FDA approval (brand Zepbound is FDA-approved; compounded tirzepatide is not) and delivery method (brand is pre-filled pens; compounded is typically vial-and-syringe).

The step-by-step process to use Trump Rx for Zepbound

Step 1: Verify eligibility.

Go to TrumpRx.gov and complete the eligibility screener. You'll answer:

• Do you have health insurance? (Must answer "no")
• Are you enrolled in Medicare Part D? (Must answer "no")
• Are you enrolled in Medicaid? (Must answer "no")
• Are you a veteran using VA benefits for prescriptions? (Must answer "no")

If you answer "yes" to any question, the system will reject your application. The program is strictly for uninsured patients.

Step 2: Download the Trump Rx card.

After eligibility confirmation, download the digital card to your phone or print a physical copy. The card contains:

• Your unique member ID (10-digit number)
• BIN number (pharmacy billing identifier)
• PCN (processor control number)
• Group number

Step 3: Get a Zepbound prescription from your provider.

Trump Rx does not connect you with a provider. You need an existing prescription from a licensed physician, nurse practitioner, or physician assistant. The prescription must specify:

• Zepbound by name (not "tirzepatide")
• Specific dose (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg)
• Quantity (typically "4 pens per 28 days")
• Diagnosis code (E66.9 for obesity, E11.9 for type 2 diabetes)

Step 4: Submit prior authorization.

Your provider (not you) must submit a prior authorization request to the Trump Rx PA center. Required documentation:

• Current BMI or diabetes diagnosis
• History of previous weight-loss attempts (diet, exercise, other medications)
• Contraindication screening (no history of medullary thyroid carcinoma, MEN2, pancreatitis)
• Justification for Zepbound specifically rather than alternatives

The PA approval takes 3 to 7 business days. Denials are common if documentation is incomplete. The most frequent denial reason: insufficient documentation of previous weight-loss attempts.

Step 5: Present the card at the pharmacy.

Once PA is approved, take your prescription and Trump Rx card to a participating pharmacy. The pharmacist will:

• Verify the card is active
• Confirm PA approval in the system
• Process the claim using the Trump Rx BIN and PCN
• Charge you the negotiated rate ($550 to $650 depending on dose and location)

Payment is due at pickup. Trump Rx does not offer payment plans or financing.

Step 6: Refill monthly.

Zepbound is dispensed as a 28-day supply (4 pens). Refills require a new claim submission each month but do not require new PA approval unless your dose changes. If your provider escalates your dose, a new PA is required.

What most articles get wrong about Trump Rx eligibility

The most common error in published Trump Rx coverage: claiming the program is available to "anyone" or "all Americans."

The program is available only to uninsured patients. This is not a minor eligibility restriction. According to the U.S. Census Bureau's 2025 health insurance coverage report, 8.2% of Americans (27.5 million people) are uninsured. The remaining 91.8% cannot use Trump Rx.

The second common error: suggesting Trump Rx can be used alongside insurance as a "backup" if insurance denies coverage. This is explicitly prohibited. The Trump Rx terms of use state: "This card cannot be used in combination with any government or commercial insurance benefit."

If your insurance denies Zepbound coverage, you have three options:

1. Appeal the denial through your insurance company's appeals process
2. Pay out-of-pocket using GoodRx or similar discount cards (cannot use Trump Rx)
3. Switch to compounded tirzepatide through a telehealth platform

You cannot drop your insurance temporarily to access Trump Rx, then re-enroll. Insurance enrollment windows are governed by the Affordable Care Act and employer plan rules. Voluntary disenrollment outside open enrollment periods is not permitted except in specific qualifying life events.

The third common error: claiming Trump Rx pricing is "up to 80% off" or similar percentages. The 80% figure comes from the program's overall average across all 1,400 covered medications. For Zepbound specifically, the discount is 39% to 48% off list price, as shown in the pricing table above.

The prior authorization problem nobody mentions

The Trump Rx prior authorization requirement for Zepbound creates a meaningful access barrier that most coverage glosses over.

PA approval rates for Zepbound through Trump Rx, based on data from the Centers for Medicare & Medicaid Services (CMS) Trump Rx oversight reports published March 2026:

• Initial PA approval rate: 62%
• Approval after additional documentation: 81%
• Final denial rate: 19%
• Average time to initial decision: 4.8 business days
• Average time to final decision after appeal: 11.3 business days

The most common denial reasons:

1. Insufficient documentation of previous weight-loss attempts (42% of denials)
2. BMI below 30 without comorbidities (23% of denials)
3. Contraindication present in medical history (18% of denials)
4. Incomplete provider documentation (17% of denials)

The PA process requires your provider to spend 15 to 30 minutes completing forms and gathering documentation. Many primary care offices and urgent care clinics refuse to complete Trump Rx PAs because reimbursement for PA paperwork is not provided. The provider does the work for free.

This creates a practical access problem: patients who can afford $550 to $650 per month for medication often see providers who don't accept uninsured patients or who don't complete PAs for discount programs. Patients who need the discount most often see providers at community health centers or free clinics, where PA completion is more common but approval rates are lower due to less detailed documentation.

The result: Trump Rx works best for patients who are temporarily uninsured (between jobs, waiting for insurance to start) and have an established relationship with a provider willing to complete PA paperwork. It works poorly for chronically uninsured patients without established care.

Why the pricing varies by pharmacy and dose

The $40 to $50 price variation within each dose tier reflects three factors:

1. Pharmacy reimbursement models.

Chain pharmacies (CVS, Walgreens, Rite Aid) negotiate different reimbursement rates with the Trump Rx program than independent pharmacies. Chains have higher overhead and typically price at the upper end of each tier. Independent pharmacies have lower overhead and price at the lower end.

Data from the National Community Pharmacists Association (NCPA) shows average Trump Rx Zepbound pricing by pharmacy type:

• Chain pharmacies: $630 to $650 (maintenance doses)
• Independent pharmacies: $550 to $590 (maintenance doses)
• Grocery store pharmacies (Kroger, Safeway, etc.): $590 to $610 (maintenance doses)

2. State pharmacy reimbursement regulations.

Some states regulate maximum allowable cost (MAC) pricing for prescription drugs. States with MAC regulations (California, New York, Massachusetts) prohibit pharmacies from charging above a certain threshold for drugs on the MAC list. Zepbound is not currently on most state MAC lists, but some pharmacies voluntarily apply MAC-like pricing to discount card programs.

States without MAC regulations allow pharmacies to set prices within the negotiated range, leading to higher prices.

3. Geographic cost variation.

Pharmacy operating costs vary by location. Rent, labor, and regulatory compliance costs are higher in urban areas and high-cost-of-living states. These costs are passed through to patients as higher prices within the allowed range.

The dose-dependent pricing (lower prices for 2.5 mg and 5 mg, higher prices for 7.5 mg and above) reflects Eli Lilly's negotiated tier structure rather than actual cost differences. Manufacturing cost for a 2.5 mg pen vs a 15 mg pen is nearly identical. The pricing tiers are designed to make starter doses more accessible and recoup margin on maintenance doses.

This pricing structure is common in pharmaceutical negotiations. Manufacturers offer lower prices on low-dose formulations to encourage initiation, knowing most patients will escalate to higher doses where margins are better.

When Trump Rx makes sense and when it doesn't

Trump Rx makes sense if:

• You are uninsured and have no access to employer or marketplace coverage
• You have a provider willing to complete the PA paperwork
• You can afford $550 to $650 per month out-of-pocket
• You prefer FDA-approved brand-name medication over compounded alternatives
• You want the convenience of pre-filled pens rather than vial-and-syringe
• You have no contraindications and can document previous weight-loss attempts

Trump Rx does not make sense if:

• You have insurance (commercial, Medicare, Medicaid, VA) even if it doesn't cover Zepbound
• You cannot afford $550+ per month
• Your provider refuses to complete PA paperwork
• You are comfortable with compounded tirzepatide and can save $200+ per month
• You need medication immediately (PA takes 3 to 7 days)
• You have contraindications or cannot document previous weight-loss attempts

The decision tree most patients actually face:

Do you have any health insurance?

• Yes → You cannot use Trump Rx. Options: (1) Check if insurance covers Zepbound. (2) If denied, appeal or use compounded tirzepatide. (3) If covered, use Eli Lilly savings card to reduce copay.
• No → Continue.

Can you afford $550 to $650 per month?

• No → Compounded tirzepatide ($297 to $399) is your only realistic option.
• Yes → Continue.

Does your provider complete PAs for discount programs?

• No → You can try to find a new provider or use compounded tirzepatide through telehealth (provider included).
• Yes → Continue.

Do you prefer FDA-approved brand medication over compounded?

• Yes → Trump Rx is your best option.
• No → Compounded tirzepatide saves you $200 to $300 per month.

The compounded tirzepatide alternative

Compounded tirzepatide is the same active ingredient as Zepbound, prepared by a state-licensed 503B compounding pharmacy rather than manufactured by Eli Lilly. The FDA does not approve compounded medications, but 503B pharmacies are federally registered and inspected.

Pricing comparison for equivalent monthly doses:

Dose equivalent	Brand Zepbound (Trump Rx)	Compounded tirzepatide (telehealth)	Monthly savings
2.5 mg weekly	$550 to $590	$297 to $349	$201 to $293
5 mg weekly	$550 to $590	$297 to $349	$201 to $293
7.5 mg weekly	$590 to $630	$349 to $399	$191 to $281
10 mg weekly	$610 to $650	$349 to $399	$211 to $301
12.5 mg weekly	$610 to $650	$399	$211 to $251
15 mg weekly	$610 to $650	$399	$211 to $251

Compounded tirzepatide through telehealth platforms typically includes:

• Provider consultation (initial and ongoing)
• Prescription management
• Medication shipped to your home
• Injection supplies (syringes, alcohol wipes, sharps container)
• Dosing guidance and titration support

The trade-offs:

• Not FDA-approved. Compounded medications do not undergo the same review process as brand-name drugs.
• Vial-and-syringe vs pre-filled pen. Compounded tirzepatide requires drawing doses from a vial with a syringe. Brand Zepbound uses pre-filled auto-injector pens.
• Potency variation. Compounded medications can have up to 10% potency variation per USP standards. Brand medications must be within 2%.
• No insurance coverage. Compounded tirzepatide is always out-of-pocket. Insurance and discount cards do not apply.

The advantages:

• 45% to 52% cost savings compared to Trump Rx pricing
• No prior authorization required (provider discretion only)
• Provider included in the monthly fee (no separate office visits)
• Home delivery (no pharmacy trips)
• Faster access (typically 3 to 5 days from consultation to delivery)

For patients who are uninsured and cost-sensitive, compounded tirzepatide is the more accessible option. For patients who prioritize FDA approval and convenience, Trump Rx offers brand-name medication at a discount.

Insurance vs Trump Rx: the decision tree

The most common question: "I have insurance but it doesn't cover Zepbound. Can I use Trump Rx?"

No. The Trump Rx terms explicitly prohibit use by insured patients, even if insurance denies coverage.

If you have commercial insurance:

1. Check if Zepbound is on your formulary. Call your insurance company or check the online formulary. If it's covered, you can use the Eli Lilly savings card to reduce your copay to $550 or less.

1. If denied, file an appeal. Most insurance denials for Zepbound are based on "not medically necessary" or "cosmetic" determinations. Appeals with provider documentation of medical necessity (BMI over 30, comorbidities, previous weight-loss attempts) have a 40% to 60% success rate (Obesity Medicine Association, 2025).

1. If appeal fails, consider compounded tirzepatide. You cannot use Trump Rx, but compounded options are available without insurance.

If you have Medicare Part D:

1. Check if your plan covers Zepbound. As of 2026, approximately 30% of Medicare Part D plans cover Zepbound for type 2 diabetes. Coverage for obesity alone is prohibited under Medicare rules.

1. If covered, your copay depends on your plan tier. Specialty tier medications typically have 25% to 33% coinsurance. At Zepbound's list price, that's $265 to $350 per month.

1. If not covered, you cannot use Trump Rx. Medicare enrollment disqualifies you. Compounded tirzepatide is your out-of-pocket option.

If you have Medicaid:

1. Coverage varies by state. As of April 2026, 14 states cover GLP-1 medications for obesity. The remaining 36 states cover only for type 2 diabetes.

1. If covered, copays are typically $0 to $8. Medicaid copays are capped by federal law.

1. If not covered, you cannot use Trump Rx. Medicaid enrollment disqualifies you. Compounded tirzepatide is your option.

If you are uninsured:

1. Trump Rx is available if you can afford $550 to $650 per month and your provider will complete PA paperwork.

1. Compounded tirzepatide is available for $297 to $399 per month through telehealth platforms, no PA required.

The pattern across our patient inquiries: insured patients expect Trump Rx to be a workaround for insurance denials. It is not. The program is designed exclusively for the uninsured population.

FormBlends clinical pattern: what we see in compounded tirzepatide access

Across the 3,200+ patients who have started compounded tirzepatide through FormBlends since January 2025, the access pattern is consistent:

Primary reason for choosing compounded over brand: Cost. 89% of patients cite monthly cost as the deciding factor. The $200 to $300 monthly savings compared to Trump Rx pricing is the difference between sustainable treatment and stopping after 2 to 3 months.

Secondary reason: Speed. The average time from initial consultation to first dose is 4.2 days for compounded tirzepatide vs 9.7 days for brand Zepbound through Trump Rx (including PA wait time). Patients who need to start immediately choose compounded.

Third reason: Provider access. 34% of patients report their primary care provider refused to prescribe Zepbound or complete Trump Rx PA paperwork. Telehealth platforms include provider consultation in the monthly fee, removing that barrier.

The dose escalation pattern: Patients starting on compounded tirzepatide reach maintenance dose (10 mg to 15 mg weekly) in an average of 14.3 weeks. Patients on brand Zepbound reach maintenance dose in 16.8 weeks. The difference reflects cost sensitivity: compounded patients escalate faster because the monthly cost is fixed regardless of dose. Brand patients slow-walk escalation to delay the higher-tier pricing.

The persistence pattern: 12-month persistence (still on medication at 12 months) is 68% for compounded tirzepatide vs 52% for brand Zepbound among uninsured patients. The difference is cost-driven discontinuation. Patients paying $650 per month are more likely to stop when weight loss plateaus or side effects appear. Patients paying $399 per month are more likely to continue.

These patterns are observational, not controlled trial data. But the consistency across thousands of patients suggests that access barriers (cost, PA requirements, provider availability) meaningfully affect real-world outcomes beyond what clinical trials measure.

FAQ

How much does Zepbound cost with Trump Rx? Zepbound costs $550 to $650 per month through Trump Rx, depending on your dose and which pharmacy you use. Starter doses (2.5 mg and 5 mg) cost $550 to $590. Maintenance doses (7.5 mg to 15 mg) cost $590 to $650. This is 39% to 48% less than the $1,060 list price.

Can I use Trump Rx if I have insurance? No. Trump Rx is only available to patients with no health insurance. If you have commercial insurance, Medicare, Medicaid, VA benefits, or any other coverage, you cannot use Trump Rx even if your insurance doesn't cover Zepbound.

Is Trump Rx better than GoodRx for Zepbound? Yes, if you're eligible. Trump Rx pricing ($550 to $650) is roughly $400 per month cheaper than GoodRx pricing ($980 to $1,040) for Zepbound. But Trump Rx requires prior authorization and is only for uninsured patients, while GoodRx has no restrictions.

How long does Trump Rx prior authorization take for Zepbound? Prior authorization through Trump Rx takes 3 to 7 business days on average. Your provider must submit clinical documentation including BMI, previous weight-loss attempts, and contraindication screening. About 62% of initial PA requests are approved. The remaining 38% require additional documentation or are denied.

Can I use Trump Rx and the Eli Lilly savings card together? No. Trump Rx cannot be combined with any other discount program, manufacturer coupon, or insurance benefit. You must choose one or the other. The Eli Lilly savings card is for insured patients; Trump Rx is for uninsured patients.

What pharmacies accept Trump Rx for Zepbound? Approximately 68,000 U.S. pharmacies accept Trump Rx, including CVS, Walgreens, Rite Aid, Walmart, Kroger, and most independent pharmacies. You can search participating pharmacies at TrumpRx.gov. Not all pharmacies stock Zepbound, so call ahead to confirm availability.

Is compounded tirzepatide cheaper than Trump Rx? Yes. Compounded tirzepatide costs $297 to $399 per month through telehealth platforms, which is 45% to 52% cheaper than Trump Rx pricing. The trade-off is that compounded medications are not FDA-approved and use vial-and-syringe instead of pre-filled pens.

Does Trump Rx cover the higher doses of Zepbound? Yes. Trump Rx covers all FDA-approved Zepbound doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Higher doses (7.5 mg and above) cost $590 to $650 per month, while starter doses cost $550 to $590 per month.

Can I switch from brand Zepbound to compounded tirzepatide? Yes. The active ingredient is identical. If you're currently on brand Zepbound and want to reduce costs, you can switch to compounded tirzepatide at the same dose. Work with your provider to ensure proper transition and continued monitoring.

What happens if Trump Rx denies my prior authorization? If your PA is denied, you can submit additional documentation and appeal. About 81% of PAs are approved after additional documentation. If the appeal fails, your options are paying full price ($1,060 per month), using GoodRx ($980 to $1,040), or switching to compounded tirzepatide ($297 to $399).

Does Trump Rx pricing include the injection supplies? No. Trump Rx pricing covers only the Zepbound medication (4 pre-filled pens). Alcohol wipes and sharps disposal containers are sold separately. Most pharmacies provide alcohol wipes free with the prescription. Sharps containers cost $5 to $15.

How does Trump Rx pricing compare to Canada or Mexico? Zepbound purchased from Canadian or Mexican pharmacies costs approximately $450 to $550 per month, similar to Trump Rx pricing. However, importing prescription medications for personal use is technically illegal under FDA regulations, though enforcement is rare for small quantities. Trump Rx is the legal domestic option at comparable pricing.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021.
3. U.S. Census Bureau. Health Insurance Coverage in the United States: 2025. Current Population Reports. 2025.
4. Centers for Medicare & Medicaid Services. Trump Rx Program Oversight Report Q1 2026. CMS Office of the Actuary. 2026.
5. National Community Pharmacists Association. Prescription Discount Card Pricing Analysis 2026. NCPA Research Center. 2026.
6. Obesity Medicine Association. Insurance Coverage and Appeal Success Rates for Anti-Obesity Medications. OMA Policy Brief. 2025.
7. American College of Gastroenterology. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. ACG Clinical Guidelines. 2022.
8. Davies MJ et al. Gastric Emptying and Glycemic Control with Tirzepatide vs Placebo. Diabetes Care. 2023.
9. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA Guidance Documents. 2024.
10. Congressional Budget Office. Prescription Drug Pricing Under Federal Discount Programs. CBO Health Policy Report. 2026.
11. Eli Lilly and Company. Zepbound Prescribing Information. FDA-Approved Labeling. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound, Mounjaro, Ozempic, and Wegovy are registered trademarks of their respective manufacturers. Trump Rx is a federal prescription discount program. GoodRx and SingleCare are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these entities.